Memantine Augmentation in Obsessive-Compulsive Disorder

Phase 1/2 Completed 15 enrolled Stanford University

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether memantine is safe and effective when used as an augmentation to standard treatment for Obsessive-Compulsive Disorder (OCD).

Timeline

Start: 2006-01
Primary completion: 2008-06
Completion: 2008-06

Publications

Results Aboujaoude E, Barry JJ, Gamel N. Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. J Clin Psychopharmacol. 2009 Feb;29(1):51-5. doi: 10.1097/JCP.0b013e318192e9a4.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Memantine	Unknown	10 mg	Oral

Memantine Augmentation in Obsessive-Compulsive Disorder

Summary

Timeline

Publications

Drugs

Indications